Robin Hamilton Selected Research

Robin Hamilton Research Topics

13	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 12/2010
5	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2020 - 05/2010
3	Macular Edema 12/2016 - 05/2010
2	Choroidal Neovascularization 01/2022 - 12/2010
2	Cataract (Cataracts) 05/2017 - 09/2002
1	COVID-19 01/2022
1	Chronic Disease (Chronic Diseases) 01/2020
1	Diabetes Mellitus 02/2019
1	Retinal Perforations 01/2018
1	Rupture 05/2017
1	Alcoholism (Alcohol Abuse) 01/2017
1	Eye Hemorrhage 05/2016
1	Hyperemia 05/2016
1	Pain (Aches) 05/2016
1	Dehydration (Water Stress) 01/2016
1	Retinal Detachment (Retinal Detachments) 09/2012
1	Retinitis 09/2012
1	Acute Retinal Necrosis Syndrome 09/2012
1	HIV Infections (HIV Infection) 11/2010
1	Tuberculosis (Tuberculoses) 11/2010
1	Ocular Hypertension (Glaucoma, Suspect) 09/2002
1	Glaucoma 09/2002

8	Ranibizumab (Lucentis)FDA Link 01/2020 - 12/2010
5	afliberceptIBA 01/2022 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 05/2016
3	Fluorescein (Funduscein)FDA LinkGeneric 03/2013 - 05/2010
2	brolucizumabIBA 01/2022 - 05/2016
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2016
1	Endothelial Growth FactorsIBA 10/2020
1	Vascular Endothelial Growth FactorsIBA 01/2020
1	microplasminIBA 01/2018
1	N-acetyltryptophanamide (NATA)IBA 12/2017
1	P-2 (P 2)IBA 12/2017
1	Capsules (Microcapsules)IBA 05/2017
1	Immunoglobulin FragmentsIBA 05/2016
1	Antiviral Agents (Antivirals)IBA 09/2012
1	Acyclovir (Aciclovir)FDA LinkGeneric 09/2012
1	Valacyclovir (Valtrex)FDA LinkGeneric 09/2012
1	Isoniazid (Ftivazide)FDA LinkGeneric 11/2010
1	Bevacizumab (Avastin)FDA Link 05/2010